Events
Conferences, congresses and webinars where Philogen presents its science.
Philogen to attend the Immunotherapy of Cancer Conference (ITOC) in Munich on March 21-23, 2024.
Prof. Dario Neri, PhD, (CEO and CSO of Philogen) is giving a presentation entitled “Immunocytokines”. Follow the link here for more details
Philogen to attend the Immuno-Oncology Summit Europe in London on April 23-25, 2024.
Follow the link here for more details
Following the announcements of this morning, Philogen management is inviting you to a Webinar on December 5 at 15:00 GMT | 16:00 CET.
Please contact us at ir@philogen.com or follow the link below to register to the event…
Philogen to attend the Annual Meeting Cancéropôle Grand Sud-Ouest in Arcachon on November 22-24, 2023.
Prof. Dario Neri, PhD, (CEO and CSO of Philogen) is giving a presentation entitled “From encoded combinatorial libraries to clinical-stage targeted…
Philogen is inviting you to a Webinar on October 18 at 14:00 GMT | 15:00 CET following the exciting announcement on our Phase III trial of Nidlegy™ in locally advanced melanoma
The Webinar will be hosted by Prof. Dr. Dario Neri (CEO and CSO), Dr. Laura Baldi (CFO), Dr. Emanuele Puca (Investor Relations). Please follow the link below to…
Philogen to attend the 12th annual Cell Culture & Bioprocessing Congress in London on November 07-08, 2023.
Dr. Mattia Matasci is giving a presentation entitled “Philogen’s Platform for the Development of Immunocytokines”. Follow the link for more details
Philogen to attend the PEGS Europe 2023 congress in Lisbon on November 14-16, 2023
Dr. Roberto De Luca will give a talk entitled “Tripokin: Best-in-Class potential for tumor targeted Interleukin-2 (IL2) potentiated by Tumor Necrosis Factor…
Philogen kindly invites you to attend a virtual briefing for analysts on 2 October 2023 to discuss Company’s Half Year 2023 Results
We are delighted to invite you to our virtual briefing on 2 October 2023 to discuss the Company’s Half Year 2023 Results. Prof. Dr. Dario Neri, Chief Executive…
Philogen to attend the ESMO congress in Madrid on October 20-24, 2023
Prof. Dr. Nicolas Mach, on behalf of Philogen, is presenting a poster about the Phase I DODEKA study on October 23rd, entitled “Phase I dose-escalation trial…
Philogen to attend the Festival of Biologics 2023 congress in Basel on October 10-12, 2023
Dr. Samuele Cazzamalli (Head of Chemistry) will give a talk entitled “Small Molecule Therapeutics targeting Fibroblast Activation Protein in the tumor…
Philogen to attend the World ADC 2023 congress in San Diego on October 16-19, 2023
Dr. Samuele Cazzamalli (Head of Chemistry) will give a virtual talk entitled “Pan-tumoral Small Molecule-Drug Conjugates Targeting Fibroblast Activation Protein…
Philogen to attend the EFMC International Symposium on Chemical Biology 2023 congress in Basel on November 16-18, 2023
Dr. Samuele Cazzamalli (Head of Chemistry) will give a talk entitled “Small Molecule Therapeutics Targeting Fibroblast Activation Protein in the Tumor…
Philogen to attend the Drug Conjugates in Directed Therapy in Darmstadt on August 23-25, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on August 25th, entitled “From encoded libraries to targeted therapeutics ”. Aureliano Zana (third…
Philogen kindly invites you to attend a virtual briefing for analysts on 5 June 2023 to discuss the Company’s latest updates.
Prof. Dr. Dario Neri, Chief Executive Officer, Dr. Laura Baldi, Chief Financial Officer, and Dr. Emanuele Puca, Head of Investor Relations, will host a 1-hour…
Philogen to attend the Antibody Engineering & Therapeutics Europe 2023 in Amsterdam on June 6-8, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 6th of June 2023 entitled “Immunocytokines with Activity on Demand”. Dr. Roberto De Luca…
Philogen to attend the Immuno-Oncology Summit Europe 2023 in London, on June 20-22, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 20th of June 2023 entitled “Antibody-Cytokine Fusions Targeting the Tumor Microenvironment…
Philogen to attend AACR Annual Meeting in Orlando on April 14-18, 2023
Prof. Dr. Dario Neri (CEO and CSO), Dr. Covelli (CMO), Dr. Dakhel, Dr. De Luca, Dr. Cazzamalli, Dr. Galbiati, Dr. Puca, Matilde Bocci, Eleonora Prodi, Sara…
Philogen to attend Stifel European Healthcare Summit in Bordeaux on June 28-30, 2023
Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event and will be available for 1o1 meetings with Investors.
Philogen to attend the 19th PEGSBOSTON in Boston, on May 15-19, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a KEYNOTE presentation on the 18th of May 2023 entitled “Antibody-Cytokine Fusions for the Treatment of…
Philogen to attend Mid & Small | London 2023 Conference on April 20, 2023
Prof. Dario Neri (CEO and CSO), and Emanuele Puca (Investor Relations) will participate at the event to present Philogen and its programs to the financial…
Philogen to attend the 74th Mosbacher Kolloquium in Mosbach/Baden, on March 23-25, 2023
Prof. Dr. Dario Neri (CEO and CSO), is giving a presentation on the 23rd of March 2023 entitled “Novel developments on immunocytokines” Follow the link for more…
Philogen to attend 19th EADO Congress on April 20-22, 2023
Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome. The dermato-oncology team from St. Gallen will give a…
Philochem to attend the 71st American Society for Mass Spectrometry Conference on June 4-8, 2023
Dr. Ettore Gilardoni (Head of Bio-MS) will present a poster entitled: Proteomic analysis reveals insights into the mechanism of the Intra-cork approach for…
Philogen to attend the Lund Spring Symposium in Lund on May 22-24, 2023
Prof. Dr. Dario Neri (CEO and CSO) is participating as a speaker at Lund Spring Symposium. Follow the link for more details.
Philogen to attend the European Bispecific and Multispecific Antibody congress in Amsterdam on the 22nd and 23rd of February, 2023
Philogen announces its attendance at the European Bispecific and Multispecific Antibody congress in Amsterdam. Dr. Roberto De Luca (Head of Antibody…
Philogen to attend the 7th Annual Next-Gen Immuno-Oncology Conference congress in London on the 9th and 10th of March, 2023
Philogen announces its attendance at the Annual Next-Gen Immuno-Oncology Conference congress in London. Dr. Roberto De Luca (Head of Antibody Therapeutics at…
Philogen to attend Mediobanca 5th MidCap Conference on January 18, 2023 in Milan
Philogen announces its attendance at the 5th MidCap Conference organised by Mediobanca. Prof. Dario Neri (CEO and CSO), Laura Baldi (CFO), and Emanuele Puca…
Philogen to attend the 13th World ADC conference in London on the 13th and 14th of March, 2023
Philogen announces its attendance at World ADC2023 in London. Dr. Samuele Cazzamalli (Head of Small Molecule Therapeutics at Philochem) is giving a lecture on…
Philogen to attend the JP Morgan on January 9-12, 2023 in San Francisco
Philogen announces its attendance at JP Morgan 2023. Prof. Dr. Dario Neri, CEO and CSO of Philogen, and Dr. Emanuele Puca, Investor Relations and Business…
Philogen to attend Melanoma Bridge in Naples, 1-3 December 2022
Philogen is Sponsor at the 13th edition of Melanoma Bridge in Naples, 1-3 December 2022.